[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
August 1982

Valproic Acid: Treatment of Myoclonus in Dyssynergia Cerebellaris Myoclonica

Arch Neurol. 1982;39(8):527-528. doi:10.1001/archneur.1982.00510200069016

• Valproic acid produced marked reduction in myoclonus in a patient with dyssynergia cerebellaris myoclonica (DCM), resulting in substantial functional improvement. These results justify a trial of valproic acid in patients with DCM who are disabled by myoclonus.